Alzheimer's Drug Discovery Foundation logo
Program

Diagnostics Accelerator

Funds Alzheimer's disease biomarker and diagnostic tools for earlier, easier, and more accurate detection.

The Diagnostics Accelerator is ADDF's collaborative biomarker and diagnostics initiative for Alzheimer's disease and related dementias. Launched in July 2018, it combines philanthropic capital with a venture mindset, was built to support easier, more accurate, and earlier diagnosis, and is backed by a partner pool totaling $100 million.

The program is now closed to unsolicited applications, and t

Max award
Realistic median
Success rate
Decision time

No upcoming rounds verified. Cadence: Annual.

Last verified: 28 May 2026Source: www.alzdiscovery.org